- Positron Emission Tomography-Computed Tomography Parameters Predict Efficacy of Immunotherapy in Head and Neck Squamous Cell Carcinomas
Songtao Zhang et al, 2021, Frontiers in Oncology CrossRef - Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab
Kosuke Ueda et al, 2022, Japanese Journal of Clinical Oncology CrossRef - Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC
Weijie Ma et al, 2021, Biomarker Research CrossRef - Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients
Jun-Liang Li et al, 2022, Oral Oncology CrossRef - Modeling of radiation effects to immune system: a review
Wonmo Sung et al, 2022, Journal of the Korean Physical Society CrossRef - Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
Jong Chul Park et al, 2022, Current Oncology CrossRef - Impact of lymphopenia on efficacy of nivolumab in head and neck cancer patients
Mathieu Césaire et al, 2023, European Archives of Oto-Rhino-Laryngology CrossRef - A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors
Dengxiong Kang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef - Immune‐modified Glasgow prognostic score: A new prognostic marker for head and neck cancer
Kosuke Terazawa et al, 2022, Head & Neck CrossRef - Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols
Catherine T. Haring et al, 2023, Cancer CrossRef - Neutrophil‐to‐lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta‐analysis
Yukinori Takenaka et al, 2022, Head & Neck CrossRef - Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study
Ekasak Thiangphak et al, 2023, Obstetrics & Gynecology Science CrossRef - Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives
Luis A. Godoy et al, 2023, Biomarker Research CrossRef